Keros Therapeutics (KROS) VP Finance Annita Tanini Sells 1,224 Shares

What Happened
Annita Tanini, the Corporate Controller & VP, Finance of Keros Therapeutics (KROS), sold 1,224 shares on Aug 18, 2026 for a total reported value of $12,595. The reported weighted-average price was $10.29; the shares were sold in multiple transactions at prices ranging from $10.14 to $10.50. According to the filing, these sales were automatic “sell-to-cover” transactions to satisfy tax withholding related to the vesting of restricted stock units, and were not at the reporting person’s discretion.

Key Details

• Transaction date: Aug 18, 2026. Filing date (Form 4): Aug 20, 2026 (appears timely).
• Shares sold: 1,224; weighted-average price: $10.29; price range: $10.14–$10.50.
• Total reported proceeds: $12,595.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote F1: Sale was automatic under issuer’s sell-to-cover policy to cover tax withholding on RSU vesting.
• Footnote F2: Price is weighted average; reporting person can provide a breakdown of shares sold at each price on request.

Context
Sell-to-cover transactions are routine tax-withholding actions tied to equity vesting and typically do not reflect a change in the insider’s view of the company. This was not an open discretionary sale by the insider but an automatic sale to cover taxes on vested restricted stock units.